226 related articles for article (PubMed ID: 29596553)
1. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA
JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553
[TBL] [Abstract][Full Text] [Related]
2. Disease course of patients with pericentral retinitis pigmentosa.
Sandberg MA; Gaudio AR; Berson EL
Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
[TBL] [Abstract][Full Text] [Related]
3. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
[TBL] [Abstract][Full Text] [Related]
4. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
5. ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Willett WC
Arch Ophthalmol; 2012 Jun; 130(6):707-11. PubMed ID: 22332205
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
[TBL] [Abstract][Full Text] [Related]
7. Disease course in patients with autosomal recessive retinitis pigmentosa due to the USH2A gene.
Sandberg MA; Rosner B; Weigel-DiFranco C; McGee TL; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5532-9. PubMed ID: 18641288
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
[TBL] [Abstract][Full Text] [Related]
9. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.
Hoffman DR; Hughbanks-Wheaton DK; Pearson NS; Fish GE; Spencer R; Takacs A; Klein M; Locke KG; Birch DG
JAMA Ophthalmol; 2014 Jul; 132(7):866-73. PubMed ID: 24805262
[TBL] [Abstract][Full Text] [Related]
10. Long-term visual prognoses in patients with retinitis pigmentosa: the Ludwig von Sallmann lecture.
Berson EL
Exp Eye Res; 2007 Jul; 85(1):7-14. PubMed ID: 17531222
[TBL] [Abstract][Full Text] [Related]
11. Long-term decline of central cone function in retinitis pigmentosa evaluated by focal electroretinogram.
Falsini B; Galli-Resta L; Fadda A; Ziccardi L; Piccardi M; Iarossi G; Resta G
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7701-9. PubMed ID: 23111612
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
[TBL] [Abstract][Full Text] [Related]
13. Visual Function in Carriers of X-Linked Retinitis Pigmentosa.
Comander J; Weigel-DiFranco C; Sandberg MA; Berson EL
Ophthalmology; 2015 Sep; 122(9):1899-906. PubMed ID: 26143542
[TBL] [Abstract][Full Text] [Related]
14. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
Birch DG; Anderson JL; Fish GE
Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
[TBL] [Abstract][Full Text] [Related]
15. Time Course of Disease Progression of PRPF31-mediated Retinitis Pigmentosa.
Kiser K; Webb-Jones KD; Bowne SJ; Sullivan LS; Daiger SP; Birch DG
Am J Ophthalmol; 2019 Apr; 200():76-84. PubMed ID: 30582903
[TBL] [Abstract][Full Text] [Related]
16. S-cone function in patients with retinitis pigmentosa.
Swanson WH; Birch DG; Anderson JL
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3045-55. PubMed ID: 8407212
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba.
Berson EL; Remulla JF; Rosner B; Sandberg MA; Weigel-DiFranco C
Arch Ophthalmol; 1996 May; 114(5):560-3. PubMed ID: 8619765
[TBL] [Abstract][Full Text] [Related]
18. Disease course of patients with unilateral pigmentary retinopathy.
Potsidis E; Berson EL; Sandberg MA
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9244-9. PubMed ID: 21989720
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
[TBL] [Abstract][Full Text] [Related]
20. Multifocal electroretinography in retinitis pigmentosa.
Seeliger M; Kretschmann U; Apfelstedt-Sylla E; Rüther K; Zrenner E
Am J Ophthalmol; 1998 Feb; 125(2):214-26. PubMed ID: 9467449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
